Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Completed 4

Sponsor Class

OTHER 2FED 2

Study Type

Interventional 4

Sponsor

Conditions

Dupuytren Contracture 4Rare Diseases 2Connective Tissue Diseases 2Arthritis 2

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Collagenases × Clear all
NCT02725528 2023-07-18

EXTEND

McMaster University

Phase 3 Completed
22 enrolled 15 charts

Dupuytren Contracture

NCT01450397 2017-04-17

MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex

Hospital for Special Surgery, New York

Phase 4 Completed
5 enrolled 5 charts

Dupuytren Contracture

NCT00004409 2015-03-25

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 2 Completed
36 enrolled

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

NCT00014742 2015-03-25

Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 3 Completed
72 enrolled

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡